The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Colestid     N'-(2-aminoethyl)-N-[2-(2...

Synonyms: COLESTIPOL, Cholestabyl, NSC-147003, NSC147003, LS-182744, ...
This record was replaced with 8197.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of UN2320


Psychiatry related information on UN2320


High impact information on UN2320


Chemical compound and disease context of UN2320


Biological context of UN2320


Anatomical context of UN2320


Associations of UN2320 with other chemical compounds


Gene context of UN2320


Analytical, diagnostic and therapeutic context of UN2320


  1. Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol. Vega, G.L., Grundy, S.M. JAMA (1987) [Pubmed]
  2. Regulation of biliary cholesterol secretion. Functional relationship between the canalicular and sinusoidal cholesterol secretory pathways in the rat. Nervi, F., Marinović, I., Rigotti, A., Ulloa, N. J. Clin. Invest. (1988) [Pubmed]
  3. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Thompson, G.R., Maher, V.M., Matthews, S., Kitano, Y., Neuwirth, C., Shortt, M.B., Davies, G., Rees, A., Mir, A., Prescott, R.J. Lancet (1995) [Pubmed]
  4. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis. Glueck, C.J. Ann. Intern. Med. (1982) [Pubmed]
  5. Long-term treatment of hypercholesterolemia with colestipol hydrochloride. Ryan, J.R., Jain, A.K., McMahon, F.G. Clin. Pharmacol. Ther. (1975) [Pubmed]
  6. Treating serum lipid abnormalities in high-priority patients. Blankenhorn, D.H., Hodis, H.N. Postgraduate medicine. (1991) [Pubmed]
  7. Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia. Kinosian, B.P., Eisenberg, J.M. JAMA (1988) [Pubmed]
  8. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholeserolemia heterozygotes. 1983. Bilheimer, D.W., Grundy, S.M., Brown, M.S., Goldstein, J.L. Atherosclerosis. Supplements. (2004) [Pubmed]
  9. Heterogeneous expression of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase genes in the rat liver lobulus. Twisk, J., Hoekman, M.F., Mager, W.H., Moorman, A.F., de Boer, P.A., Scheja, L., Princen, H.M., Gebhardt, R. J. Clin. Invest. (1995) [Pubmed]
  10. Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia. Illingworth, D.R., Phillipson, B.E., Rapp, J.H., Connor, W.E. Lancet (1981) [Pubmed]
  11. Probucol with colestipol in the treatment of hypercholesterolemia. Dujovne, C.A., Krehbiel, P., Decoursey, S., Jackson, B., Chernoff, S.B., Pitterman, A., Garty, M. Ann. Intern. Med. (1984) [Pubmed]
  12. Effect of lovastatin or niacin combined with colestipol and regression of coronary atherosclerosis. Brown, B.G. Eur. Heart J. (1992) [Pubmed]
  13. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia. Seplowitz, A.H., Smith, F.R., Berns, L., Eder, H.A., Goodman, D.S. Atherosclerosis (1981) [Pubmed]
  14. Modification of the carcinogenic process in colorectal cancer by endogenous and exogenous factors: effect of colestipol hydrochloride on tumors induced by dimethylhydrazine. Daugherty, J.P. Environ. Health Perspect. (1983) [Pubmed]
  15. Primary hypercholesterolemia: effect of treatment on serum lipids, lipoprotein fractions, cholesterol absorption, sterol balance, and platelet aggregation. Briones, E.R., Steiger, D., Palumbo, P.J., Kottke, B.A. Mayo Clin. Proc. (1984) [Pubmed]
  16. Long-term effects of colestipol (U-26,597 A) on plasma lipids in familial type II hyperbetalipoproteinaemia. Fellin, R., Briani, G., Balestrieri, P., Baggio, G., Baiocchi, M.R., Crepaldi, G. Atherosclerosis (1975) [Pubmed]
  17. Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol. Schwarz, K.B., Goldstein, P.D., Witztum, J.L., Schonfeld, G. Pediatrics (1980) [Pubmed]
  18. Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide. Neuvonen, P.J., Kivistö, K., Hirvisalo, E.L. British journal of clinical pharmacology. (1988) [Pubmed]
  19. Safety considerations with gastrointestinally active lipid-lowering drugs. Jacobson, T.A., Armani, A., McKenney, J.M., Guyton, J.R. Am. J. Cardiol. (2007) [Pubmed]
  20. Sulfhydryl/disulfide forms of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase. Ness, G.C., McCreery, M.J., Sample, C.E., Smith, M., Pendleton, L.C. J. Biol. Chem. (1985) [Pubmed]
  21. Thyroid hormone and thyrotropin levels in patients placed on colestipol hydrochloride. Witztum, J.L., Jacobs, L.S., Schonfeld, G. J. Clin. Endocrinol. Metab. (1978) [Pubmed]
  22. In vitro studies to investigate the reasons for the low potency of cholestyramine and colestipol. Benson, G.M., Haynes, C., Blanchard, S., Ellis, D. Journal of pharmaceutical sciences. (1993) [Pubmed]
  23. Effects of colestipol hydrochloride on drug absorption in the rat II. Phillips, W.A., Ratchford, J.M., Schultz, J.R. Journal of pharmaceutical sciences. (1976) [Pubmed]
  24. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia. Malloy, M.J., Kane, J.P., Kunitake, S.T., Tun, P. Ann. Intern. Med. (1987) [Pubmed]
  25. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia. Vecchio, T.J., Linden, C.V., O'Connell, M.J., Heilman, J. Arch. Intern. Med. (1982) [Pubmed]
  26. The effect of drugs on bile flow and composition. An overview. Okolicsanyi, L., Lirussi, F., Strazzabosco, M., Jemmolo, R.M., Orlando, R., Nassuato, G., Muraca, M., Crepaldi, G. Drugs (1986) [Pubmed]
  27. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease. Kuo, P.T., Wilson, A.C., Kostis, J.B., Moreyra, A.E. Am. J. Cardiol. (1986) [Pubmed]
  28. Apparent reduced absorption of gemfibrozil when given with colestipol. Forland, S.C., Feng, Y., Cutler, R.E. Journal of clinical pharmacology. (1990) [Pubmed]
  29. The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment. Korhonen, T., Hannuksela, M.L., Seppänen, S., Kervinen, K., Kesäniemi, Y.A., Savolainen, M.J. Eur. J. Clin. Pharmacol. (1999) [Pubmed]
  30. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia. Weisweiler, P. Metab. Clin. Exp. (1989) [Pubmed]
  31. Transcriptional and posttranscriptional regulation of rat hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase by thyroid hormones. Simonet, W.S., Ness, G.C. J. Biol. Chem. (1988) [Pubmed]
  32. Identification and characterization of a mouse oxysterol 7alpha-hydroxylase cDNA. Schwarz, M., Lund, E.G., Lathe, R., Björkhem, I., Russell, D.W. J. Biol. Chem. (1997) [Pubmed]
  33. Heterogeneity of rat liver parenchyma in cholesterol 7 alpha-hydroxylase and bile acid synthesis. Ugele, B., Kempen, H.J., Kempen, J.M., Gebhardt, R., Meijer, P., Burger, H.J., Princen, H.M. Biochem. J. (1991) [Pubmed]
  34. Colestipol-induced changes in LDL composition and metabolism. II. Studies in humans. Young, S.G., Witztum, J.L., Carew, T.E., Krauss, R.W., Lindgren, F.T. J. Lipid Res. (1989) [Pubmed]
  35. The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies. Lithell, H., Vessby, B., Boberg, J., Hellsing, K. Atherosclerosis (1980) [Pubmed]
  36. Beneficial effect of a bile acid resin binder on enteral feeding induced diarrhea. DeMeo, M., Kolli, S., Keshavarzian, A., Borton, M., Al-Hosni, M., Dyavanapalli, M., Shiau, A., Tu, N., Frommel, T., Zarling, E., Goris, G., Shawaryn, G., Mobarhan, S. Am. J. Gastroenterol. (1998) [Pubmed]
  37. The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients. Insull, W., Davidson, M.H., Demke, D.M., Dujovne, C.A., Eckert, S.M., Ginsberg, D., Goldberg, A.C., Hodis, H.N., Hughes, T.A., Kane, J.P. Atherosclerosis (1995) [Pubmed]
  38. Effects of cholestyramine and colestipol on the plasma concentrations of propranolol. Hibbard, D.M., Peters, J.R., Hunninghake, D.B. British journal of clinical pharmacology. (1984) [Pubmed]
WikiGenes - Universities